Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balistreri

Showing results (471-480 of 548) with videos related to

Pageof 55
Sort By:
Oncogene|August 29, 2006
Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registryA Acquaviva, L Ciccolallo, R Rondelli, et al.
Journal of Dermatological Science|December 28, 2020
A new deep learning approach integrated with clinical data for the dermoscopic differentiation of early melanomas from atypical neviLinda Tognetti, Simone Bonechi, Paolo Andreini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.
Gastroenterology|November 2, 2010
The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis CKathleen B Schwarz, Regino P Gonzalez-Peralta, Karen F Murray, et al.
Biorxiv : the Preprint Server for Biology|August 19, 2022
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the pre-hairpin intermediate of the spike proteinKailu Yang, Chuchu Wang, Alex J B Kreutzberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2022
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike proteinKailu Yang, Chuchu Wang, Alex J B Kreutzberger, et al.
Frontiers in Medicine|September 9, 2024
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registriesAntonio Vitale, Judith Palacios-Olid, Valeria Caggiano, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11Karen F Murray, William F Balistreri, Sanjay Bansal, et al.
Plos Pathogens|November 14, 2024
Dynamin independent endocytosis is an alternative cell entry mechanism for multiple animal virusesRavi Ojha, Anmin Jiang, Elina Mäntylä, et al.
Hepatology Communications|February 15, 2023
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling studyRegino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, et al.
Pageof 55

Showing results (471-480 of 548) with videos related to

Sort By:
Pageof 55
Oncogene|August 29, 2006
Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registryA Acquaviva, L Ciccolallo, R Rondelli, et al.
Journal of Dermatological Science|December 28, 2020
A new deep learning approach integrated with clinical data for the dermoscopic differentiation of early melanomas from atypical neviLinda Tognetti, Simone Bonechi, Paolo Andreini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.
Gastroenterology|November 2, 2010
The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis CKathleen B Schwarz, Regino P Gonzalez-Peralta, Karen F Murray, et al.
Biorxiv : the Preprint Server for Biology|August 19, 2022
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the pre-hairpin intermediate of the spike proteinKailu Yang, Chuchu Wang, Alex J B Kreutzberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2022
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike proteinKailu Yang, Chuchu Wang, Alex J B Kreutzberger, et al.
Frontiers in Medicine|September 9, 2024
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registriesAntonio Vitale, Judith Palacios-Olid, Valeria Caggiano, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11Karen F Murray, William F Balistreri, Sanjay Bansal, et al.
Plos Pathogens|November 14, 2024
Dynamin independent endocytosis is an alternative cell entry mechanism for multiple animal virusesRavi Ojha, Anmin Jiang, Elina Mäntylä, et al.
Hepatology Communications|February 15, 2023
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling studyRegino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, et al.
Pageof 55